Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
30 participants
OBSERVATIONAL
2011-04-30
2013-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Potassium Supplementation in CKD
NCT03253172
Blood Pressure and Diurnal Variation in Sodium, Potassium, and Water Excretion
NCT00005204
Effect of Plasma Sodium Concentration on Blood Pressure Regulators During Hemodialysis
NCT03578510
Nocturnal Blood Pressure Dipping and Ventricular Repolarization in Hypertension
NCT07200856
Clinical Outcome of Patients With Resistant Hypertension Undergoing Renal Denervation
NCT04722159
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy group
15 persons with normal renal function
Blood withdrawal
blood withdrawal every 2 hours during 24 hours
Renal failure
15 persons with renal failure (GFR \< 60 ml/min)
Blood withdrawal
blood withdrawal every 2 hours during 24 hours
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blood withdrawal
blood withdrawal every 2 hours during 24 hours
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* normal renal function and impaired renal function (GFR \< 60 ml/min) respectively
Exclusion Criteria
* anaemia (Hb\<10 mg/dl)
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Biotronik SE & Co. KG
INDUSTRY
University of Erlangen-Nürnberg Medical School
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Roland E. Schmieder, MD
Role: PRINCIPAL_INVESTIGATOR
Department of Nephrology and Hypertension, University of Erlangen-Nürnberg Medical School
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinical Research Unit, Department of Nephrology and Hypertension, University of Erlangen-Nürnberg
Erlangen, , Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Schmidt ST, Ditting T, Deutsch B, Schutte R, Friedrich S, Kistner I, Ott C, Raff U, Veelken R, Schmieder RE. Circadian rhythm and day to day variability of serum potassium concentration: a pilot study. J Nephrol. 2015 Apr;28(2):165-72. doi: 10.1007/s40620-014-0115-7. Epub 2014 Jul 3.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
4408
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.